Trial Profile
pilot study of systemic combination therapy with TS-1 and IFN for hepatocellular carcinoma patients with extrahepatic metastases who do not response to systemic combination therapy with TS-1 and cisplatin.
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Interferon (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 19 Jul 2013 Status changed from active, no longer recruiting to discontinued as reported University Hospital Medical Information Network - Japan.
- 09 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 28 Jan 2011 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.